Arbutus Biopharma Corporation ABUS Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's change in AR?
- Arbutus Biopharma Corporation (ABUS) reported change in AR of -$1.16M in Q1 2026.
- How has Arbutus Biopharma Corporation's change in AR changed year-over-year?
- Arbutus Biopharma Corporation's change in AR increased by 5.5% year-over-year, from -$1.23M to -$1.16M.
- What is the long-term trend for Arbutus Biopharma Corporation's change in AR?
- Over 2 years (2021 to 2025), Arbutus Biopharma Corporation's change in AR has grown at a 83.6% compound annual growth rate (CAGR), from -$446K to -$1.5M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.